Pre-steady-state uptake of -glucose by the human erythrocyte is inconsistent with a circulating carrier mechanism

Simulation shows that the four-state mobile carrier model for sugar transport in which the asymmetry arises from unequal rate constants of inward and outward translation of the free-carrier and carrier-sugar complex, does not fit with the observed data for pre-steady-state uptake recently obtained by A.G. Lowe and A.R. Walmsley ((1987) Biochim. Biophys. Acta 903, 547–550). The main reason for this discrepancy is that pre-steady-state fluxes are determined mainly by the dissociation constants K_s of glucose and maltose for the external sites, rather than the K_m (zero-trans_oi) of glucose and the K_i of maltose. The data are also inconsistent with other forms of asymmetric carrier but are fairly consistent with a symmetrical carrier with high-affinity sites for -glucose or with a fixed site carrier model.     

The inhibition of erythrocyte glyceraldehyde-3-phosphate dehydrogenase in situ PMR studies

The kinetics of inhibition of human erythrocyte glyceraldehyde-3-phosphate dehydrogenase by iodoacetate were studied in the intact cell and in vitro. The kinetics were determined using ¹H-NMR to follow solvent exchange of ¹H and ²H at the C-2 position of lactate. The exchange occurs via a series of enzyme-catalysed reactions, including that catalysed by glyceraldehyde-3-phosphate dehydrogenase. A direct assay with quenching of the inhibition was also used to check the results. Iodoacetate was shown to act as an active site-directed inhibitor of the dehydrogenase. The enzyme inhibition patterns, which are characterised by a binding step and a kinetic step, are similar in situ and in vitro. Membrane binding, however, was found to alter the inhibition pattern for the enzyme in vitro.     

ESR spectral changes induced by chlorpromazine in spin-labeled erythrocyte ghost membranes

chlorpromazine interacted preferentially with membrane proteins rather than membrane lipids in the initial incorporation into human erythrocyte ghosts, as demonstrated by means of the fluorescence quenching and a maleimide spin label. In this state the membrane fluidity increased. At higher concentrations of chlorpromazine, the membrane fluidity decreased and a motionally restricted signal from fatty acid spin labels appeared predominantly. However, no such signal appeared in protein-free vesicles. The temperature and pH dependences of the outer hyperfine splitting of this restricted signal were very similar to those of bovine serum albumin. On the basis of sodium dodecyl sulfate-polyacrylamide gel electrophoresis of chlorpromazine-treated and -untreated ghosts, it was found that there was no significant difference in membrane proteins between both samples except for the changes of a few bands which were not directly concerned with the occurrence of this restricted signal. These results suggest that the fatty acid spin labels bind preferably to membrane proteins as the lipid domain becomes packed with chlorpromazine.     

Modulation of glucose transport in human red blood cells by ATP

Depletion of energy stores of human red cells decreases the maximum transport capacity, $\text{J}{}_{\mathrm{<mtext>m</mtext>}}$, for glucose transport to a value one-third or less of that found in red cells from freshly drawn blood. There is no change in $\text{K}{}_{\mathrm{<mtext>m</mtext>}}$. Hemolysis and resealing of red cells with ATP or ADP reverses the decrease in $\text{J}{}_{\mathrm{<mtext>m</mtext>}}$. The maximum effect occurs at concentrations of ATP in the normal range for red cells, however, there is little effect from ADP concentrations in its normal range in freshly drawn red cells. Hemolysis and resealing with ATP gives an increase in $\text{J}{}_{\mathrm{<mtext>m</mtext>}}$ and an increase in differential labeling by photolytic labeling with tritiated cytochalasin B. Most of the activation is lost after a second hemolysis-reseal without ATP but about 25% of the activation remains.     

Nucleoside transport in cultured mammalian cells multiple forms with different sensitivity to inhibition by nitrobenzylthioinosine or hypoxanthine

The zero-trans influx of 500 μM uridine by CHO, P388, L1210 and L929 cells was inhibited by nitrobenzylthioinosine (NBTI) in a biphasic manner; 60–70% of total uridine influx by CHO cells and about 90% of that in P388, L1210 and L929 cells was inhibited by nmolar concentrations of NBTI (ID₅₀ = 3?10 nM) and is designated NBTI-sensitive transport. The residual transport activity, designated NBTI-resistant transport, was inhibited by NBTI only at concentrations above 1 μM (ID₅₀ = 10?50 μM). S49 cells exhibited only NBTI-sensitive uridine transport, whereas Novikoff cells exhibited only NBTI-resistant uridine transport. In all instances NBTI-sensitive transport correlated with the presence of between 7·10⁴ and 7·10⁵ high-affinity NBTI binding sites/cell (K_d = 0.3?1 nM). Novikoff cells lacked such sites. The two types of nucleoside transport, NBTI-resistant and NBTI-sensitive, were indistinguishable in substrate affinity, temperature dependence, substrate specificity, inhibition by structurally unrelated substances, such as dipyridamole or papaverine, and inhibition by sulfhydryl reagents or hypoxanthine. We suggest, therefore, that a single nucleoside transporter can exist in an NBTI-sensitive and an NBTI-resistant form depending on its disposition in the plasma membrane. The sensitive form expresses a high-affinity NBTI binding site(s) which is probably made up of the substrate binding site plus a hydrophobic region which interacts with the lipophilic nitrobenzyl group of NBTI. The latter site seems to be unavailable in NBTI-resistant transporters. The proportion of NBTI-resistant and sensitive uridine transport was constant during proportion of NBTI-resistant and sensitive uridine transport was constant during progression of P388 cells through the cell cycle and independent of the growth stage of the cells in culture. There were additional differences in uridine transport between cell lines which, however, did not correlate with NBTI sensitivity and might be related to the species origin of the cells. Uridine transport in Novikoff cells was more sensitive to inhibition by dipyridamole and papaverine than that in all other cell lines tested, whereas uridine transport in CHO cells was the most sensitive to inactivation by sulfhydryl reagents.     

The stereospecific d-glucose transport protein in cholate extracts of human erythrocyte membranes Molecular sieve chromatography and estimation of molecular weight

Cholate extracts of human erythrocyte membranes (Lundahl, P., Acevedo, F., Fröman, G. and Phutrakul, S. (1981) Biochim. Biophys. Acta 644, 101–107) were fractionated by molecular sieve chromatography on Sepharose 6B, and the size and molecular weight of the active d-glucose transporter were estimated. The eluent contained 10 or 12.5 mM cholate, since higher concentrations inactivated the glucose transporter, and lower concentrations resulted in aggregation. The chromatographic distribution of the transport activity was reproducible, but was broader than one would expect for a homogeneous component. In the presence of 20 mM EDTA and 5 mM dithioerythritol, a combination which affords a highly stable transport activity, a molecular weight of $\text{400 000 ± 20 000}$ (Stokes' radius 5.9 nm) was estimated for the smallest active component. This value represents an upper limit, since the molecular weight of a non-spherical component would have been overestimated, and since bound cholate was calculated to represent about 12% of the molecular weight. The activity was completely recovered upon rechromatography. In 10 mM EDTA and 10 mM 2-mercaptoethanol, the estimated molecular weight of the smallest active component was $\text{210 000 ± 15 000}$, and this component was not stable upon rechromatography in 10 mM EDTA and 10 mM 2-mercaptoethanol. In the absence of chelating and reducing agents, cholate extracts from membranes which had been kept for 5 days at 4°C showed three additional active components smaller than 200 000 in molecular weight. Most of the phospholipids eluted later than the active components of molecular weight 400 000 or 210 000, in all experiments. Electrophoretic analysis in dodecyl sulfate of the chromatographic eluents indicates that at least one of the band 3-polypeptides (nomenclature according to Steck, T.L. (1974) J. Cell Biol. 62, 1–19) is a component of the active transporter. This band 3-polypeptide, which we denote 3.3, has an apparent molecular weight of 88 000. The stable transporter of molecular weight 400 000 might be a tetramer of the 3.3-polypeptide. Alternatively, a dimer of the 3.3-polypeptide in complex with lipids might account for this molecular weight. If the 3.3-polypeptide is the transporter subunit and if it binds cytochalasin B with high affinity ($\text{1.8 · 10}{}^5$ sites/cell) the recovered activity per 3.3-polypeptide is around 40% A degradation product of the 3.3-component (possibly a 4.5-component) might account for the unstable active transporter of molecular weight 210 000.     

Role of sulfhydryl groups in band 3 in the inhibition of phosphate transport across erythrocyte membrane in visceral leishmaniasis

Membrane destabilization in erythrocytes plays an important role in the premature hemolysis and development of anemia during visceral leishmaniasis (VL). Marked degradation of the anion channel protein band 3 is likely to allow modulation of anion flux across the red cell membrane in infected animals. The present study describes the effect of structural modification of band 3 on phosphate transport in VL using (31)P NMR. The result showed progressive decrease in the rate and extent of phosphate transport during the post-infection period. Interdependence between the intracellular ionic levels seems to be a determining factor in the regulation of anion transport across the erythrocyte membrane in control and infected conditions. Infection-induced alteration in band 3 made the active sites of transport more susceptible to binding with amino reactive agents. Inhibition of transport by oxidation of band 3 and subsequent reversal by reduction using dithiothreitol suggests the contribution of sulfhydryl group in the regulation of anion exchange across the membrane. Quantitation of sulfhydryl groups in the anion channel protein showed the inhibition to be closely related to the decrease of sulfhydryl groups in the infected hamsters. Downregulation of phosphate transport during leishmanial infection may be ascribed to the sulfhydryl modification of band 3 resulting in the impaired functioning of this protein under the diseased condition.     

Evidence of multiple operational affinities for d-glucose inside the human erythrocyte membrane

1. 1. The Michaelis-Menten parameters of labelled d-glucose exit from human erythrocytes at 2°C into external solution containing 50 mM d-galactose were obtained. The K_m is 3.4 ± 0.4 mM, V 17.3 ± 1.4 mmol · 1⁻¹ cell water · min⁻¹ for this infinite-trans exit procedure.

2. 2. The kinetic parameters of equilibrium exchange of d-glucose at 2°C are K_m = 25 ± 3.4 mM, V 30 ± 4.1 mmol · 1⁻¹ cell water · min⁻¹.

3. 3. The K_m for net exit of d-glucose into solutions containing zero sugar is 15.8 ± 1.7 mM, V 9.3 ± 3.3 mol 9.3 ± 3.3 mol · 1⁻¹ cell water · min⁻¹.

4. 4. This experimental evidence corroborates the previous finding of Hankin, B.L., Lieb, W.R. and Stein, W.D. [(1972) Biochim. Biophys. Acta 255, 126–132] that there are sites with both high and low operational affinities for d-glucose at the inner surface of the human erythrocyte membrane. This result is inconsistent with current asymmetric carrier models of sugar transport.

Systems of l-leucine transport into Saccharomyces cerevisiae protoplasts

l-[¹⁴C]Leucine transport into Saccharomyces cerevisiae protoplasts involves two systems (1 and 2) with different kinetic parameters. The K_T values for these systems are of the same order as those for intact yeast cells. These results suggest that the proteins related to the affinity constants are located in the cytoplasmic membrane.     

The transport of chloroquine across human erythrocyte membranes is mediated by a simple symmetric carrier

The kinetic properties of the mediated transport of chloroquine in human erythrocytes are investigated. The high rates of translocation across the cell membrane and high adsorbance properties to glass surfaces have led to the development of new techniques for measuring initial rates of transport. Three different methodological procedures are used to accomplish a complete kinetic characterization of the system. All measurements were done at 25°C. Under zero-trans conditions the system displays complete symmetry, the Michaelis constants being 39.2±2.4 μM for influx and 36.6±5.6 μM for efflux. The respective maximal velocities are 206.4±36.0 μM·min^?1 and 190.0±7.8 μM·min^?1. Under equilibrium-exchange conditions the Michaelis constant is 108.6±15.6 μM and the maximal velocity is 630.3±50.4 μM·min^?1. This 3-fold increase in both K and V over the zero-trans values indicates that the rate-limiting step in the transport of chloroquine is the movement of the unloaded carrier. The kinetic data are consistent with the prediction of a simple carrier model.     

Asymmetric binding of steroids to internal and external sites in the glucose carrier of erythrocytes

Steroids inhibit glucose transport in erythrocytes by binding to sites in the carrier which are exposed on both the outer and inner surfaces of the cell membrane. Some steroids are bound almost exclusively at inner sites (androstendione and androstandione), while others are bound about as firmly on one side as the other (corticosterone). Still others exhibit a moderate preference for the internal site (deoxycorticosterone). The inhibition is in all cases competitive with respect to a substrate which is bound at the same surface of the membrane as the inhibitor. However, in experiments on substrate entry, internally bound inhibitors act in an apparently non-competitive fashion, as expected if the carrier model is valid. This behaviour explains the appearance of competitive, non-competitive and mixed inhibitions with different steroids (Lacko, L., Wittke, B. and Geck, P. (1975) J. Cell Physiol. 86, 673–680).     

Inhibition of glucose transport by benzoquinone and the addition product of benzoquinone and dithiothreitol

Hydroxylated benzene derivatives inhibited transport of d-glucose into calf-thymocyte plasma-membrane vesicles. The relative effectiveness of these was pyrogallol >hydroquinone catechol phloroglucinol. The most thoroughly studied of these agents, hydroquinone, produced weak, immediate inhibition when first added to membranes (K_i > 10 mM). This was followed by a gradual, time-dependent inhibition of the residual transport activity. The instantaneous inhibition could not be prevented by any agent tested, whereas the time-dependent phase was affected by reducing agents and superoxide dismutase. Several reducing agents (dithiothreitol, glutathione, NADH, ascorbate, bisulfite but not cysteine) prevented, while superoxide dismutase and cysteine potentiated time-dependent inhibition when added to the membrane suspension simultaneously with hydroquinone. NADH and ascorbate also prevented, whereas dithiothreitol potentiated, further time-dependent inhibition when added to membranes 2 h after hydroquinone. In contrast, all three reducing agents arrested time-dependent inhibition when added 2 h after pyrogallol. Numerous agents had no effect on time-dependent hydroquinone inhibition: oxidants (H₂O₂), metal chelators (EDTA, bathophenanthroline disulfonate, Desferral), radical scavengers (benzoate, ethanol), anti-oxidants (butylated hydroxytoluene) and catalase. Benzoquinone, an oxidation product of hydroquinone, was a much more potent inhibitor (K_i 1 mM) than hydroquinone. Several reducing agents (ascorbate, NADH, bisulfite) prevented this effect, while cysteine and dithiothreitol potentiated it. Below 300 μM, benzoquinone had little or no effect on sugar transport with or without glutathione or cysteine. Addition of dithiothreitol to benzoquinone (10–300 μM) resulted in potent inhibition of sugar transport (K_i 50 μM). Maximal inhibition occurred with a 1 : 1 mol ratio of these agents or with excess dithiothreitol. The inhibitory agent from benzoquinone and dithiothreitol lost potency in the presence of air and membranes, but was stable for hours in the presence of either of these alone. dl-threo-1,4-bis(2,5-dihydroxyphenylthio)-2,3-butanediol was obtained from the reaction of equimolar quantities of dithiothreitol and benzoquinone in ethanol. The structure of this adduct was established by spectroscopic and chemical methods. This compound exhibited all of the properties of the inhibitor which had been formed from benzoquinone and dithiothreitol in aqueous solution.     

Peroxynitrite oxidizes erythrocyte membrane band 3 protein and diminishes its anion transport capacity

We describe an altered membrane band 3 protein-mediated anion transport in erythrocytes exposed to peroxynitrite, and relate the loss of anion transport to cell damage and to band 3 oxidative modifications. We found that peroxynitrite down-regulate anion transport in a dose dependent relation (100–300 μmoles/l). Hemoglobin oxidation was found at all peroxynitrite concentrations studied. A dose-dependent band 3 protein crosslinking and tyrosine nitration were also observed. Band 3 protein modifications were concomitant with a decrease in transport activity. ( ? )-Epicatechin avoids band 3 protein nitration but barely affects its transport capacity, suggesting that both processes are unrelated. N-acetyl cysteine partially reverted the loss of band 3 transport capacity. It is concluded that peroxynitrite promotes a decrease in anion transport that is partially due to the reversible oxidation of band 3 cysteine residues. Additionally, band 3 tyrosine nitration seems not to be relevant for the loss of its anion transport capacity.     

Peroxynitrite oxidizes erythrocyte membrane band 3 protein and diminishes its anion transport capacity

We describe an altered membrane band 3 protein-mediated anion transport in erythrocytes exposed to peroxynitrite, and relate the loss of anion transport to cell damage and to band 3 oxidative modifications. We found that peroxynitrite down-regulate anion transport in a dose dependent relation (100-300 μmoles/l). Hemoglobin oxidation was found at all peroxynitrite concentrations studied. A dose-dependent band 3 protein crosslinking and tyrosine nitration were also observed. Band 3 protein modifications were concomitant with a decrease in transport activity. ( - )-Epicatechin avoids band 3 protein nitration but barely affects its transport capacity, suggesting that both processes are unrelated. N-acetyl cysteine partially reverted the loss of band 3 transport capacity. It is concluded that peroxynitrite promotes a decrease in anion transport that is partially due to the reversible oxidation of band 3 cysteine residues. Additionally, band 3 tyrosine nitration seems not to be relevant for the loss of its anion transport capacity.     

The monosaccharide transport system of the human erythrocyte. Orientation upon reconstitution

Treatment of intact human erythrocytes with trypsin had no effect upon either the rate of hexose transport or the binding of cytochalasin B to the transport system. In contrast, proteolysis of inside-out vesicles prepared from human erythrocyte membranes inactivated both hexose transport and cytochalasin B binding. When purified hexose transporter, reconstituted into phospholipid vesicles of undetermined size, was treated with trypsin, approx. 50% of the cytochalasin B binding activity was lost. This loss correlated with a decrease in the amount of the transporter polypeptide, as assayed by gel electrophoresis. These results show that the orientation of the transporter can be established through trypsin treatment in conjunction with cytochalasin B binding. Small unilamellar vesicles containing transporter were prepared by sonication of larger species and by a cycle of cholate solubilization and removal of the detergent. In the former case, the transporter orients almost randomly, whereas in the latter approx. 75% of the transporters have the cytoplasmic domain extemal.     

Peroxyl-oxidized erythrocyte membrane band 3 protein with anion transport capacity is degraded by membrane-bound proteinase

Human red blood cells anion exchange protein (band 3) exposed to peroxyl radicals produced by thermolysis of 2,2'-azo-bis(2-amidinopropane) (AAPH) is degraded by proteinases that prevent accumulation of oxidatively damaged proteins. To assess whether this degradation affects anion transport capacity we used the anionic fluorescent probe 2-[N-(7-nitrobenz-2-oxa-1,3-diazol-4-y) amino] ethanosulfonate (NBD-taurine). A decrease of band 3 function was observed after exposure to peroxyl radicals. In the presence of proteinase inhibitors the decrement of anion transport through band 3 was smaller indicating that removal achieved by proteinases includes oxidized band 3 which still retain transport ability. Proteinases recognize band 3 aggregates produced by peroxyl radicals as was evaluated by immunoblotting. It is concluded that decrease of band 3 transport capacity may result from a direct protein oxidation and from its degradation by proteinases and that band 3 aggregates removal may prevent macrophage recognition of the senescent condition which would lead to cell disposal.     

Hydroxyapatite chromatography of the D-glucose transport protein of human erythrocyte membranes

Absorption, circular dichroism, electron spin resonance and resonance Raman spectra of a blue copper protein, plantacyanin from cucumber peel have been measured and these spectral properties compared with those of other blue copper proteins. From the spectral properties, amino acid analysis and redox potential, we discuss the active site and redox properties of this protein.